Keith S. Kennedy
CFO & COOMr. Keith S. Kennedy, C.F.A., C.P.A, serves as Chief Operating Officer of CareDx, Inc since September 12, 2024 and has been its Chief Financial Officer since February 26, 2026. He was Chief Financial Officer of PharmaLogic Holdings Corp until 2025. He served as Chief Operating Officer of Veracyte, Inc. since July 1, 2019 until May 15, 2021. Mr. Kennedy had been the Chief Financial Officer of Veracyte, Inc. since December 06, 2016 until May 15, 2021 and had been its Secretary since November 2017 until July 2020. Prior to joining Veracyte, Inc., Mr. Kennedy provided strategic counsel and consulting services from his consulting practice from September 2015 to November 2016, including advisory services to Pennant Park Investment Advisors. From February 2012 to August 2015, Mr. Kennedy served at MCG Capital Corporation, a commercial finance company, as President, Director and Chief Executive Officer from April 2014 to August 2015, as Chief Financial Officer, Chief Accounting Officer and Treasurer from May 2012 to March 2014 and as Executive Vice President and Managing Director from February 2012 to May 2012. From May 2011 to February 2012, Mr. Kennedy served as an Executive-in-Residence at Arlington Capital Partners. From October 2009 to April 2011, Mr. Kennedy pursued Principal investing, including serving as Executive-in-Residence at J.I. Kislak, Inc from March 2010 to September 2010. From October 2002 to September 2009, Mr. Kennedy served as Managing Director at GE Capital, Inc. From September 1999 to October 2002, Mr. Kennedy worked as a Manager of transaction services at Ernst & Young LLP. Mr. Kennedy served in the U.S. Air Force from December 1992 to December 1996. Mr. Kennedy holds a B.S. in Accounting with high distinction from Indiana University in 1992 and holds an M.B.A. from the College of William & Mary in 1995. Mr. Kennedy is a chartered Financial Analyst and certified public accountant.
公司职务
- 公司名称CareDx, Inc.股票代码CDNA职务CFO & COO共事同僚
- JWJohn Walter HannaPresident, CEO & Director
- MDMichael D. GoldbergIndependent Chairman
- JAJeffrey A. NovackGeneral Counsel & Secretary
- JMJessica MengChief Commercial Officer
- KRKashif RathoreChief Technology Officer
- CMChristine M. CournoyerIndependent Director
- RBR. Bryan RiggsbeeIndependent Director
- FEFred E. CohenIndependent Director
